Barclays’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.26M | Sell |
148,977
-708,672
| -83% | -$6.75M | ﹤0.01% | 2608 |
|
|
2025
Q4 | $10.4M | Buy |
857,649
+446,032
| +108% | +$5.42M | ﹤0.01% | 1647 |
|
|
2025
Q3 | $4.81M | Sell |
411,617
-84,413
| -17% | -$1.01M | ﹤0.01% | 2230 |
|
|
2025
Q2 | $4.6M | Buy |
496,030
+794
| +0.2% | +$6.21K | ﹤0.01% | 2207 |
|
|
2025
Q1 | $3.63M | Buy |
495,236
+163,994
| +50% | +$1.26M | ﹤0.01% | 2162 |
|
|
2024
Q4 | $2.83M | Sell |
331,242
-180,280
| -35% | -$1.76M | ﹤0.01% | 2637 |
|
|
2024
Q3 | $4.45M | Buy |
511,522
+138,441
| +37% | +$1.14M | ﹤0.01% | 2188 |
|
|
2024
Q2 | $2.55M | Buy |
373,081
+11,988
| +3% | +$74K | ﹤0.01% | 1969 |
|
|
2024
Q1 | $3.29M | Buy |
361,093
+250,987
| +228% | +$1.78M | ﹤0.01% | 2154 |
|
|
2023
Q4 | $491K | Buy |
110,106
+84,143
| +324% | +$249K | ﹤0.01% | 3885 |
|
|
2023
Q3 | $81.5K | Buy |
25,963
+4,840
| +23% | +$19.8K | ﹤0.01% | 3671 |
|
|
2023
Q2 | $109K | Sell |
21,123
-258,564
| -92% | -$1.54M | ﹤0.01% | 3522 |
|
|
2023
Q1 | $1.47M | Sell |
279,687
-39,147
| -12% | -$186K | ﹤0.01% | 2435 |
|
|
2022
Q4 | $896K | Buy |
318,834
+315,567
| +9,659% | +$1.04M | ﹤0.01% | 2895 |
|
|
2022
Q3 | $14K | Sell |
3,267
-13,102
| -80% | -$66K | ﹤0.01% | 4186 |
|
|
2022
Q2 | $66K | Sell |
16,369
-16,112
| -50% | -$60.9K | ﹤0.01% | 3940 |
|
|
2022
Q1 | $161K | Sell |
32,481
-92,831
| -74% | -$515K | ﹤0.01% | 3553 |
|
|
2021
Q4 | $873K | Buy |
125,312
+49,575
| +65% | +$385K | ﹤0.01% | 2911 |
|
|
2021
Q3 | $757K | Buy |
75,737
+59,369
| +363% | +$667K | ﹤0.01% | 2950 |
|
|
2021
Q2 | $231K | Sell |
16,368
-49,263
| -75% | -$749K | ﹤0.01% | 3484 |
|
|
2021
Q1 | $1.08M | Buy |
65,631
+43,203
| +193% | +$832K | ﹤0.01% | 2726 |
|
|
2020
Q4 | $464K | Sell |
22,428
-8,019
| -26% | -$119K | ﹤0.01% | 3282 |
|
|
2020
Q3 | $231K | Buy |
30,447
+876
| +3% | +$7.27K | ﹤0.01% | 3752 |
|
|
2020
Q2 | $246K | Buy |
29,571
+15,542
| +111% | +$103K | ﹤0.01% | 3906 |
|
|
2020
Q1 | $70K | Sell |
14,029
-28,436
| -67% | -$140K | ﹤0.01% | 5013 |
|
|
2019
Q4 | $168K | Sell |
42,465
-13,732
| -24% | -$47.7K | ﹤0.01% | 5162 |
|
|
2019
Q3 | $171K | Sell |
56,197
-9,566
| -15% | -$42.8K | ﹤0.01% | 5087 |
|
|
2019
Q2 | $290K | Buy |
65,763
+42,885
| +187% | +$159K | ﹤0.01% | 4787 |
|
|
2019
Q1 | $91K | Buy |
22,878
+649
| +3% | +$2.61K | ﹤0.01% | 5436 |
|
|
2018
Q4 | $88K | Sell |
22,229
-25,117
| -53% | -$138K | ﹤0.01% | 5131 |
|
|
2018
Q3 | $325K | Buy |
47,346
+23,254
| +97% | +$146K | ﹤0.01% | 4618 |
|
|
2018
Q2 | $162K | Sell |
24,092
-4,170
| -15% | -$28.6K | ﹤0.01% | 4893 |
|
|
2018
Q1 | $184K | Buy |
28,262
+24,148
| +587% | +$136K | ﹤0.01% | 4903 |
|
|
2017
Q4 | $18K | Sell |
4,114
-4,406
| -52% | -$22.5K | ﹤0.01% | 6339 |
|
|
2017
Q3 | $52K | Buy |
8,520
+7,713
| +956% | +$49.7K | ﹤0.01% | 5332 |
|
|
2017
Q2 | $7K | Sell |
807
-32,449
| -98% | -$314K | ﹤0.01% | 6154 |
|
|
2017
Q1 | $308K | Buy |
33,256
+29,983
| +916% | +$250K | ﹤0.01% | 3895 |
|
|
2016
Q4 | $27K | Buy |
3,273
+2,975
| +998% | +$23.1K | ﹤0.01% | 5484 |
|
|
2016
Q3 | $2K | Sell |
298
-3,607
| -92% | -$22K | ﹤0.01% | 6257 |
|
|
2016
Q2 | $20K | Buy |
3,905
+1,877
| +93% | +$18.6K | ﹤0.01% | 5270 |
|
|
2016
Q1 | $18K | Sell |
2,028
-3,209
| -61% | -$24.3K | ﹤0.01% | 5267 |
|
|
2015
Q4 | $47K | Sell |
5,237
-822
| -14% | -$8.87K | ﹤0.01% | 4837 |
|
|
2015
Q3 | $85K | Buy |
6,059
+1,330
| +28% | +$26.7K | ﹤0.01% | 4716 |
|
|
2015
Q2 | $99K | Buy |
4,729
+4,556
| +2,634% | +$113K | ﹤0.01% | 4681 |
|
|
2015
Q1 | $7K | Sell |
173
-2,454
| -93% | -$80.7K | ﹤0.01% | 6437 |
|
|
2014
Q4 | $61K | Buy |
+2,627
| New | +$44.2K | ﹤0.01% | 5554 |
|
Other funds holding OCUL
DTC
ACA
SR
VA
VCM
